Intelligent Bio Solutions
INBS
2 hedge funds and large institutions have $365K invested in Intelligent Bio Solutions in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$285K |
| 2 |
Jane Street
New York
|
+$154K |
Top Sellers
INBS Hedge Fund Activity: Q4 2020 in Review
2 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q4 2020, worth a combined $365K.
Buyers outnumbered sellers: 2 funds opened new INBS positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $285K.
- 2 institutional investors held Intelligent Bio Solutions (INBS) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $365K of Intelligent Bio Solutions stock for Q4 2020.
- 2 funds opened new Intelligent Bio Solutions positions in Q4 2020 and 0 closed out, a net change of +2 holders.
- The largest Intelligent Bio Solutions buyer in Q4 2020 was Anson Funds Management, an estimated $285K added.
Based on aggregated 13F filings for Q4 2020.